{"id":"W2146308079","doi":"10.1007/s11060-015-1894-y","title":"A phase II trial of tamoxifen and bortezomib in patients with recurrent malignant gliomas","year":2015,"lang":"en","type":"article","venue":"Journal of Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":false,"ca_institutions":"Columbia College","funders":"National Institutes of Health","keywords":"Medicine; Bortezomib; Internal medicine; Glioma; Phases of clinical research; Tamoxifen; Oncology; Gastroenterology; Toxicity; Surgery; Cancer; Multiple myeloma; Breast cancer; Cancer research","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003285602,0.0001255811,0.0006570742,0.0003178146,0.0000179397,0.00000467075,0.00005838223,0.00007717451,0.000009776845],"category_scores_gemma":[0.0002590568,0.00007834673,0.00007274123,0.0001821459,0.00006751113,0.00007231427,0.00004214597,0.0001879752,7.487326e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000157319,"about_ca_system_score_gemma":0.0003716686,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000007997837,"about_ca_topic_score_gemma":0.000008624941,"domain_scores_codex":[0.998619,0.0001281727,0.000623256,0.0001338779,0.0003273595,0.0001683423],"domain_scores_gemma":[0.9985928,0.0001246892,0.0006021308,0.0001217256,0.0002889757,0.0002697044],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.5306155,0.1093931,0.1939288,0.00008306674,0.0006117902,0.009468028,0.002981904,0.00001718804,0.01940962,0.00006531673,0.009446376,0.1239792],"study_design_scores_gemma":[0.6378052,0.3123322,0.03084201,0.0001857148,0.0004624389,0.0006526992,0.0001073878,0.00002694206,0.003774436,0.00007189481,0.01362958,0.0001095261],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9969227,0.0002963389,0.00000189607,0.001620189,0.0004560934,0.0004761131,0.000007066942,0.0000027601,0.0002167859],"genre_scores_gemma":[0.9993382,0.00007594296,0.000295228,0.0001546733,0.0001091824,0.000009204397,0.000003155916,0.0000119254,0.000002562222],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.202939,"threshold_uncertainty_score":0.3194887,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03661502940811316,"score_gpt":0.3307358211320278,"score_spread":0.2941207917239146,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}